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Background
B', B'/C and AE recombinant subtype of HIV-1 occupy the
top three of the most prevalent HIV-1 clades in China.
Thus, the preliminary object for HIV vaccine development
in China is to obtain an efficacious vaccine targeting these
clades. In order to assess their potencies to be used as T
cell vaccine immunogen, we compared the immunogenic-
ity of DNA vaccines containing tat, rev, integrase (C-half),
vif and nef genes derived from the above three subtypes in
mice model.
Methods
Polynecleotides encompassing tat, rev, integrase (C-half),
vif and nef genes of HIV-1cn54(B'/C), HIV-1rl42(B') and
HIV-1ae2f(AE) were synthesized respectively after codon
optimization according to the preference of homo sapi-
ens. Among these genes, tat, integrase(C-half) and nef
were modified to ensure they were safe. The synthesized
DNA fragments were transferred into plasmid vector to
generated 3 DNA vaccines for vaccination of female Balb/
c mice in a DNA prime-DNA boost regimen. IFN-γ Elispot
assay was used to read out the T cell immunity.
Results
The general magnitude of T cell response elicited by pSV-
TRIVN(ae2f) (948 ± 330 SFCs/106 splenocytes) was sig-
nificantly higher than those of pSV-TRIVN(rl42) (195.1 ±
44 SFCs/106 splenocytes) and pSV-TRIVN(cn54) (89.5 ±
17 SFCs/106 splenocytes), p < 0.01. And most potent
response was elicited by Integrase(C-half) and the second
was Vif. While, rare response was induced by Tat, Rev and
Nef.
Conclusion
Our data demonstrated that DNA vaccine derived from
HIV-1ae2f was most immunogenic among these three
DNA vaccines. And in our vaccine formulation, the C-half
of Integrase was the most immunogenic component.
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